Sunshine Biopharma Inc (SBFM)
0.93
+0.04
(+4.49%)
USD |
NASDAQ |
May 17, 16:00
0.92
-0.01
(-1.08%)
After-Hours: 20:00
Sunshine Biopharma Market Cap: 0.9249M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.9249M |
| May 16, 2024 | 0.8851M |
| May 15, 2024 | 0.8875M |
| May 14, 2024 | 0.8946M |
| May 13, 2024 | 0.8663M |
| May 10, 2024 | 0.8876M |
| May 09, 2024 | 0.908M |
| May 08, 2024 | 0.9846M |
| May 07, 2024 | 1.014M |
| May 06, 2024 | 0.9843M |
| May 03, 2024 | 0.8354M |
| May 02, 2024 | 0.8329M |
| May 01, 2024 | 0.8555M |
| April 30, 2024 | 0.8702M |
| April 29, 2024 | 0.8537M |
| April 26, 2024 | 0.9448M |
| April 25, 2024 | 0.803M |
| April 24, 2024 | 0.9249M |
| April 23, 2024 | 1.203M |
| April 22, 2024 | 1.432M |
| April 19, 2024 | 1.755M |
| April 18, 2024 | 3.302M |
| April 17, 2024 | 3.779M |
| April 16, 2024 | 6.763M |
| April 15, 2024 | 6.076M |
| Date | Value |
|---|---|
| April 12, 2024 | 7.966M |
| April 11, 2024 | 8.662M |
| April 10, 2024 | 9.756M |
| April 09, 2024 | 9.498M |
| April 08, 2024 | 9.627M |
| April 05, 2024 | 10.14M |
| April 04, 2024 | 9.149M |
| April 03, 2024 | 10.79M |
| April 02, 2024 | 8.145M |
| April 01, 2024 | 10.59M |
| March 28, 2024 | 6.017M |
| March 27, 2024 | 5.669M |
| March 26, 2024 | 5.679M |
| March 25, 2024 | 5.728M |
| March 22, 2024 | 5.868M |
| March 21, 2024 | 5.967M |
| March 20, 2024 | 5.569M |
| March 19, 2024 | 5.470M |
| March 18, 2024 | 5.321M |
| March 15, 2024 | 5.967M |
| March 14, 2024 | 4.972M |
| March 13, 2024 | 5.042M |
| March 12, 2024 | 5.281M |
| March 11, 2024 | 5.718M |
| March 08, 2024 | 5.798M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
0.072M
Minimum
Feb 18 2020
116.16M
Maximum
May 25 2021
18.53M
Average
11.94M
Median
Jun 29 2023
Market Cap Benchmarks
| Lexaria Bioscience Corp | 40.59M |
| Acasti Pharma Inc | 25.28M |
| Aurinia Pharmaceuticals Inc | 823.79M |
| Edesa Biotech Inc | 14.63M |
| Xenon Pharmaceuticals Inc | 3.004B |
Market Cap Related Metrics
| PS Ratio | 0.0093 |
| Price to Book Value | 0.0436 |
| Price | 0.93 |
| Earnings Yield | -2.12K% |